Form 8-K - Current report:
SEC Accession No. 0001213900-18-007395
Filing Date
2018-06-08
Accepted
2018-06-08 10:58:02
Documents
3
Period of Report
2017-11-26
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT f8k112617b_immudyneinc.htm 8-K 19443
2 LICENSE AGREEMENT, DATED NOVEMBER 26, 2017 BY AND BETWEEN THE IMMUDYNE PR, LLC A f8k112617bex10-1_immudyneinc.htm EX-10.1 55985
3 FIRST AMENDMENT TO LICENSE AGREEMENT, DATED MAY 20, 2018 BY AND BETWEEN THE IMMU f8k112617bex10-2_immudyneinc.htm EX-10.2 12935
  Complete submission text file 0001213900-18-007395.txt   89529
Mailing Address 1460 BROADWAY NEW YORK NY 10036
Business Address 1460 BROADWAY NEW YORK NY 10036 914-244-1777
Immudyne, Inc. (Filer) CIK: 0000948320 (see all company filings)

EIN.: 760238453 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-55857 | Film No.: 18888390
SIC: 2833 Medicinal Chemicals & Botanical Products